Neuropsychiatric adverse events of chloroquine: A real-world pharmacovigilance study using the FAERS database
Kenichiro Sato, Tatsuo Mano, Atsushi Iwata, Tatsushi Toda
doi: https://doi.org/10.1101/2020.04.10.20061358
Kenichiro Sato
1Department of Neurology, Graduate School of Medicine, University of Tokyo
Tatsuo Mano
1Department of Neurology, Graduate School of Medicine, University of Tokyo
Atsushi Iwata
1Department of Neurology, Graduate School of Medicine, University of Tokyo
2Department of Neurology, Tokyo Metropolitan Geriatric Medical Center Hospital
Tatsushi Toda
1Department of Neurology, Graduate School of Medicine, University of Tokyo
Data Availability
The data used in this study is publicly distributed from FAERS database (https://www.fda.gov), which is not owned by the authors.
Posted April 14, 2020.
Neuropsychiatric adverse events of chloroquine: A real-world pharmacovigilance study using the FAERS database
Kenichiro Sato, Tatsuo Mano, Atsushi Iwata, Tatsushi Toda
medRxiv 2020.04.10.20061358; doi: https://doi.org/10.1101/2020.04.10.20061358
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2257)
- Dermatology (201)
- Emergency Medicine (368)
- Epidemiology (11549)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3541)
- Geriatric Medicine (336)
- Health Economics (612)
- Health Informatics (2287)
- Health Policy (910)
- Hematology (333)
- HIV/AIDS (742)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3326)
- Nursing (190)
- Nutrition (504)
- Oncology (1748)
- Ophthalmology (522)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (222)
- Palliative Medicine (66)
- Pathology (435)
- Pediatrics (998)
- Primary Care Research (399)
- Public and Global Health (5974)
- Radiology and Imaging (1216)
- Respiratory Medicine (807)
- Rheumatology (367)
- Sports Medicine (311)
- Surgery (383)
- Toxicology (50)
- Transplantation (170)
- Urology (142)